WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Inc Stock Ownership - Who owns Tango Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tango Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adam CrystalPresident RD2026-06-0120,860$23.06
$480.95kSell
Adam CrystalPresident RD2026-06-0127,000$5.20
$140.40kBuy
Adam CrystalPresident RD2026-06-016,140$22.25
$136.63kSell
Adam CrystalPresident RD2026-05-011,100$22.00
$24.20kSell
Adam CrystalPresident RD2026-05-0127,000$5.20
$140.40kBuy
Adam CrystalPresident RD2026-05-0125,900$21.19
$548.90kSell
Adam CrystalPresident RD2026-04-1538,460$5.20
$199.99kBuy
Adam CrystalPresident RD2026-04-1538,460$25.00
$961.50kSell
Adam CrystalPresident RD2026-04-0127,000$5.20
$140.40kBuy
Adam CrystalPresident RD2026-04-0127,000$21.20
$572.48kSell

1 of 3

TNGX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNGX insiders and whales buy or sell their stock.

TNGX Shareholders

What type of owners hold Tango Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC16.57%23,961,472$697.76MInsider
Boxer Capital LLC10.50%15,187,092$442.25MInsider
Boxer Capital Management LLC9.46%13,679,092$398.34MInsider
Third Rock Ventures IV LP9.25%13,386,574$389.82MInsider
Rtw Investments LP9.20%13,300,620$387.31MInstitution
Adage Capital Partners GP LLC8.86%12,809,485$373.01MInstitution
Boxer Capital Management LLC7.52%10,876,219$316.72MInstitution
Tcg Crossover Management LLC7.28%10,531,071$306.66MInstitution
Fmr LLC6.85%9,905,919$288.46MInstitution
Farallon Capital Management LLC6.29%9,097,411$264.92MInstitution

1 of 3

TNGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNGX68.39%31.61%Net SellingNet Buying
KNSA59.03%10.53%Net SellingNet Selling
VKTX63.04%8.85%Net Selling
EWTX88.33%11.67%Net SellingNet Selling
ERAS76.07%23.93%Net BuyingNet Buying
View Top Biotech Stocks

Tango Therapeutics Stock Ownership FAQ

Who owns Tango Therapeutics?

Tango Therapeutics (NASDAQ: TNGX) is owned by 124.62% institutional shareholders, 57.59% Tango Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Tango Therapeutics shareholder, owning 23.96M shares representing 16.57% of the company. Ecor1 Capital LLC's Tango Therapeutics shares are currently valued at $722.20M.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.